{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:41:24Z","timestamp":1793814084496,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:00:00Z","timestamp":1631318400000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.heliyon.2021.e07993","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T12:13:55Z","timestamp":1631708035000},"page":"e07993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9400-3947","authenticated-orcid":false,"given":"Chiranjit","family":"Maity","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2021.e07993_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heliyon.2021.e07993_bib2","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1572-0241.2006.00465.x","article-title":"Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease","volume":"101","author":"McFarland","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/514958","article-title":"Mechanisms and management of antibiotic-associated diarrhea","volume":"27","author":"Hogenauer","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.heliyon.2021.e07993_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000443360","article-title":"Effects of antibiotics on gut microbiota","volume":"34","author":"Lange","year":"2016","journal-title":"Dig. Dis."},{"key":"10.1016\/j.heliyon.2021.e07993_bib5","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","article-title":"Antibiotics as deep modulators of gut microbiota: between good and evil","volume":"65","author":"Ianiro","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2021.e07993_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.chom.2019.10.011","article-title":"Recovery of the gut microbiota after antibiotics depends on host diet, community context, and environmental reservoirs","volume":"26","author":"Ng","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.heliyon.2021.e07993_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12864-020-6665-2","article-title":"The effect of antibiotics on the gut microbiome: a metagenomics analysis of microbial shift and gut antibiotic resistance in antibiotic treated mice","volume":"21","author":"Xu","year":"2020","journal-title":"BMC Genom."},{"key":"10.1016\/j.heliyon.2021.e07993_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1756283X11399115","article-title":"Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection","volume":"4","author":"Hickson","year":"2011","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrmicro2536","article-title":"Shifting the balance: antibiotic effects on host-microbiota mutualism","volume":"9","author":"Willing","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035677","article-title":"Antibiotic-induced changes in the human gut microbiota for the most commonly prescribed antibiotics in primary care in the UK: a systematic review","volume":"10","author":"Elvers","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2021.e07993_bib11","first-page":"347","article-title":"Role of the microbiome, probiotics, and 'dysbiosis therapy' in critical illness","volume":"22","author":"Wischmeyer","year":"2016","journal-title":"Curr. Opin. Crit. Care"},{"key":"10.1016\/j.heliyon.2021.e07993_bib12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.fm.2010.03.007","article-title":"Bacillus probiotics","volume":"28","author":"Cutting","year":"2011","journal-title":"Food Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00228-018-2562-x","article-title":"A\u00a0prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort","volume":"75","author":"Maity","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib14","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2036.2012.05104.x","article-title":"Meta-analysis: probiotics in antibiotic-associated diarrhoea","volume":"35","author":"Videlock","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2021.e07993_bib15","first-page":"170","article-title":"Probiotics for gastrointestinal conditions: a summary of the evidence","volume":"96","author":"Wilkins","year":"2017","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.heliyon.2021.e07993_bib16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/nu10081074","article-title":"Bacillus clausii for the treatment of acute diarrhea in children: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Ianiro","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2021.e07993_bib17","series-title":"List of Nationally Authorised Medicinal Products","year":"2017"},{"key":"10.1016\/j.heliyon.2021.e07993_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/AEM.67.2.834-839.2001","article-title":"Molecular characterization and identification of Bacillus clausii Strains marketed for use in oral bacteriotherapy","volume":"67","author":"Senesi","year":"2001","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib19","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bpj.2009.06.029","article-title":"Specific interactions of clausin, a new lantibiotic, with lipid precursors of the bacterial cell wall","volume":"97","author":"Bouhss","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.heliyon.2021.e07993_bib20","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1128\/AAC.02815-15","article-title":"Secreted compounds of the probiotic Bacillus clausii strain O\/C inhibit the cytotoxic effects induced by Clostridium difficile and Bacillus cereus toxins","volume":"60","author":"Ripert","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2021.e07993_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1186\/s12866-019-1680-7","article-title":"Composite genome sequence of Bacillus clausii, a probiotic commercially available as Enterogermina\u00ae, and insights into its probiotic properties","volume":"19","author":"Khatri","year":"2019","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib22","doi-asserted-by":"crossref","first-page":"12636","DOI":"10.1038\/s41598-020-69533-7","article-title":"Protective action of Bacillus clausii probiotic strains in an in vitro model of Rotavirus infection","volume":"10","author":"Paparo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heliyon.2021.e07993_bib23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1365-2672.2006.03042.x","article-title":"Tolerance to challenges miming gastrointestinal transit by spores and vegetative cells of Bacillus clausii","volume":"101","author":"Cenci","year":"2006","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40794-020-00120-4","article-title":"Recommendations for the adjuvant use of the poly-antibiotic\u2013resistant probiotic Bacillus clausii (O\/C, SIN, N\/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts","volume":"6","author":"De Castro","year":"2020","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"10.1016\/j.heliyon.2021.e07993_bib25","first-page":"6689","article-title":"Statement on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 14: suitability of taxonomic units notified to EFSA until March 2021","volume":"19","author":"Koutsoumanis","year":"2021","journal-title":"EFSA J"},{"key":"10.1016\/j.heliyon.2021.e07993_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/AEM.70.1.280-284.2004","article-title":"Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii","volume":"70","author":"Bozdogan","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1574-6968.2009.01633.x","article-title":"A\u00a0chromosomal chloramphenicol acetyltransferase determinant from a probiotic strain of Bacillus clausii","volume":"296","author":"Galopin","year":"2009","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.heliyon.2021.e07993_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.toxrep.2016.12.004","article-title":"Safety assesment of Bacillus clausii UBBC07, a spore forming probiotic","volume":"4","author":"Lakshmi","year":"2017","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.heliyon.2021.e07993_bib29","first-page":"102","article-title":"Antibiotic sensitivity of Bacillus clausii strains in commercial preparation","volume":"1","author":"Abbrescia","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.heliyon.2021.e07993_bib30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jam.12848","article-title":"Survival and persistence of Bacillus clausii in the human gastrointestinal tract following oral administration as spore-based probiotic formulation","volume":"119","author":"Ghelardi","year":"2015","journal-title":"J.\u00a0Appl. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib31","series-title":"Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects","year":"2000"},{"key":"10.1016\/j.heliyon.2021.e07993_bib32","series-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice [E6(R1)]","year":"1996"},{"key":"10.1016\/j.heliyon.2021.e07993_bib33","series-title":"Ethical Guidelines for Biomedical Research on Human Participants. New Delhi","year":"2006"},{"key":"10.1016\/j.heliyon.2021.e07993_bib34","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/JCM.42.3.1203-1206.2004","article-title":"Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota","volume":"42","author":"Young","year":"2004","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3349\/ymj.2018.59.1.4","article-title":"Disruption of the gut ecosystem by antibiotics","volume":"59","author":"Yoon","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.heliyon.2021.e07993_bib36","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s12866-020-01999-x","article-title":"Gut microbiota characteristics in mice with antibiotic-associated diarrhea","volume":"20","author":"Shao","year":"2020","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib37","series-title":"Effectiveness of Bacillus Clausii in Reducing Duration of Illness in Acute Diarrhoea in Children 6-59 Months of Age Admitted with Severe Dehydration","author":"Maugo","year":"2012"},{"key":"10.1016\/j.heliyon.2021.e07993_bib38","first-page":"74","article-title":"Bacillus clausii as an adjuvant therapy in acute childhood diarrhoea","volume":"14","author":"Keya","year":"2015","journal-title":"IOSR J. Dent. Med. Sci."},{"key":"10.1016\/j.heliyon.2021.e07993_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3920\/BM2018.0094","article-title":"Bacillus clausii UBBC-07 reduces severity of diarrhoea in children under 5 years of age: a double blind placebo controlled study","volume":"10","author":"Sudha","year":"2019","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.heliyon.2021.e07993_bib40","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40794-019-0089-5","article-title":"Bacillus clausii as adjunctive treatment for acute community-acquired diarrhea among Filipino children: a large-scale, multicenter, open-label study (CODDLE)","volume":"5","author":"De Castro","year":"2019","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"10.1016\/j.heliyon.2021.e07993_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.32677\/IJCH.2020.v07.i03.004","article-title":"Clinical effectiveness of Bacillus clausii and Lactic acid bacillus in acute diarrhea","volume":"7","author":"Shah","year":"2020","journal-title":"Indian J. Child Health"},{"key":"10.1016\/j.heliyon.2021.e07993_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jmmcr.0.004036","article-title":"Efficacy of Bacillus probiotics in prevention of antibiotic-associated diarrhoea: a randomized, double-blind, placebo-controlled clinical trial","volume":"1","author":"Horosheva","year":"2014","journal-title":"JMM Case Rep."},{"key":"10.1016\/j.heliyon.2021.e07993_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3920\/BM2012.0034","article-title":"Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea","volume":"4","author":"Sudha","year":"2013","journal-title":"Benef. Microbes"},{"key":"10.1016\/j.heliyon.2021.e07993_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s40121-020-00333-2","article-title":"Effect of Bacillus clausii capsules in reducing adverse effects associated with Helicobacter pylori eradication therapy: a randomized, double-blind, controlled trial","volume":"9","author":"Plomer","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.heliyon.2021.e07993_bib45","article-title":"Probiotics for the prevention of pediatric antibiotic-associated diarrhea","volume":"4","author":"Guo","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2021.e07993_bib46","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1365-2036.2004.02274.x","article-title":"Bacillus clausii therapy to reduce side-effects of anti-Helicobacter pylori treatment: randomized, double-blind, placebo controlled trial","volume":"20","author":"Nista","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2021.e07993_bib47","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/01.mcg.0000128925.06662.69","article-title":"Bacillus clausii probiotic strains: antimicrobial and immunomodulatory activities","volume":"38","author":"Urdaci","year":"2004","journal-title":"J.\u00a0Clin. Gastroenterol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib48","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1111\/febs.13338","article-title":"Molecular mechanism of PdxR \u2013 a transcriptional activator involved in the regulation of vitamin B6 biosynthesis in the probiotic bacterium Bacillus clausii","volume":"282","author":"Tramonti","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.heliyon.2021.e07993_bib49","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.scitotenv.2018.09.187","article-title":"The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of\u00a0their\u00a0potential biodegradation pathways","volume":"651","author":"Kong","year":"2019","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.heliyon.2021.e07993_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.1399-3038.2003.00102.x","article-title":"Cytokines evaluation in nasal lavage of allergic children after Bacillus clausii administration: a pilot study","volume":"15","author":"Ciprandi","year":"2004","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib51","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/00042737-200509000-00011","article-title":"Bacillus clausii effect on gene expression pattern in small bowel mucosa using DNA microarray analysis","volume":"17","author":"Di Caro","year":"2005","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib52","first-page":"943","article-title":"Bacillus clausii and gut homeostasis: state of the art and future perspectives","volume":"10","author":"Lopetuso","year":"2016","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2021.e07993_bib53","unstructured":"Prato, T. Solid composition containing bacillus-type non-pathogenic bacterial spores. US Patent No. US8039006B2 (active), Sanofi Aventis SpA. Available at https:\/\/patents.google.com\/patent\/US8039006B2\/en (2011)."},{"key":"10.1016\/j.heliyon.2021.e07993_bib54","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/tropej\/fmv050","article-title":"Bacillus clausii for prevention of late-onset sepsis in preterm infants: a randomized controlled trial","volume":"61","author":"Tewari","year":"2015","journal-title":"J.\u00a0Trop. Pediatr."},{"key":"10.1016\/j.heliyon.2021.e07993_bib55","first-page":"211","article-title":"Bacillus clausii - the probiotic of choice in the treatment of diarrhoea","volume":"5","author":"Jayanthi","year":"2015","journal-title":"J.\u00a0Yoga Phys. Ther."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402102096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402102096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:48:08Z","timestamp":1773769688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402102096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S240584402102096X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07993","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic efficacy of probiotic Alkalihalobacillus clausii 088AE in antibiotic-associated diarrhea: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2021.e07993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e07993"}}